dobutamine has been researched along with Hepatocellular Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jian, Y; Shiqiang, S; Xiaochen, J; Yu, N; Zongjian, S | 1 |
| Cheong, JY; Daza, J; Ebert, MP; Falconer, T; Hripcsak, G; Itzel, T; Park, J; Park, RW; Roig, A; Teufel, A; Wiest, I | 1 |
2 other study(ies) available for dobutamine and Hepatocellular Carcinoma
| Article | Year |
|---|---|
The impacts of corrected left ventricular ejection time combined with dobutamine on hepatocellular carcinoma patients.
Topics: Blood Loss, Surgical; Carcinoma, Hepatocellular; Dobutamine; Humans; Liver Neoplasms; Oxygen | 2022 |
Efficacy of Co-Medications in Patients with Alcoholic Liver Disease.
Topics: Carcinoma, Hepatocellular; Dobutamine; Dopamine; Female; Humans; Liver Diseases, Alcoholic; Liver Neoplasms; Metoprolol | 2023 |